Disease Control Data, nr-axSpA
Por um escritor misterioso
Descrição
Review separate clinical trial data relating to the efficacy of RINVOQ® in non-radiographic axial spondyloarthritis patients. See Important Safety Info, including BOXED WARNING, and full Prescribing Info.
Australian Consensus Statements for the Assessment and Management of Non-radiographic Axial Spondyloarthritis
Comparison of clinical characteristics between adult-onset and juvenile-onset non-radiographic axial spondyloarthritis in Chinese patients: results from the COCAS cohort, European Journal of Medical Research
The Prevalence of Non-radiographic Axial Spondyloarthritis Among Patients with Inflammatory Back Pain from Northwest and South Africa: Data from a Noninterventional, Cross-Sectional Study
Axial Spondyloarthritis Disease Education Resources - Lilly Medical Education
FDA Approval Of The First nr-AxSpA Biologics Projecting Regulatory Market Dynamics
Pan American League of Associations for Rheumatology recommendations for the management of axial spondyloarthritis
Current differentiation between radiographic and non-radiographic axial spondyloarthritis is of limited benefit for prediction of important clinical outcomes: data from a large, prospective, observational cohort
The Complement System in Spondyloarthritis: What Do We Know? - touchIMMUNOLOGY
Disease Control Data, nr-axSpA
de
por adulto (o preço varia de acordo com o tamanho do grupo)
